Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022

Published 14/12/2022, 20:56
© Reuters.  These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022
V1TA34
-

Benzinga - Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global. Healthcare REITs tend to invest in properties operated by hospitals, assisted living facilities, and medical offices, among others.

Although healthcare REITs will continue to experience negative effects from interest rate hikes, they are still well-positioned to benefit from their sustainable demographics, and some have held up considerably well so far. For instance, National Health is only down roughly 4.2% year-to-date, while Ventas is only down about 11% year-to-date.

When the Federal Reserve eventually decides to pivot to a dovish policy stance, this may signal a prime buying opportunity for certain REITs. Here are two healthcare real estate investment trusts to throw on your watchlist, that have held up well compared to the overall market.

Also Read: This Analyst Sees 33% Returns For A Stock Benefitting From A Crumbling US Electric Grid

National Health Investors Inc. (NYSE: NHI) is offering a forward dividend yield of 6.35% or $3.60 per share annually, conducting quarterly payments, with an inconsistent track record of increasing its dividends.

National Health specializes in sale-leaseback, joint venture, mortgage and mezzanine financing for independent, assisted and memory care communities, skilled nursing facilities, medical office buildings and specialty hospitals.

National Health has partnered with 28 operating partners that manage roughly 190 properties across 32 states.

Ventas Inc . (NYSE: NYSE:VTR) is offering a forward dividend yield of 3.96% or $1.80 per share annually, through quarterly payments, with an infrequent track record of increasing its dividends. Ventas owns a diversified healthcare portfolio of over 1,200 properties spread across senior housing, medical office, hospital, life science, and skilled nursing/post-acute care.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Debra A. Cafaro, Ventas Chairperson and CEO said, “In the fourth quarter, we expect accelerating year-over-year same-store SHOP cash NOI growth of 15% to 21% and positive contributions from all other segments amidst a continuing dynamic macroeconomic environment,” adding that, “the Ventas balance sheet is well positioned with an outstanding 2023 maturity profile.”

​​To read about the latest developments in the industry, check out Benzinga’s real estate home page

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.